menu
    • menu

    Company profile for Novast Laboratories

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Novast Laboratories Ltd. is located in Nantong, Jiangsu, China and is part of the Pharmaceutical and Medicine Manufacturing Industry. Novast Laboratories Ltd. has 500 total employees across all of its locations. (Employees figure is estimated). There are 3 companies in the Novast Laboratories Ltd. corporate family.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Novast LaboratoriesChina Flag
    Country
    Country
    China
    Address
    Address
    1692 Xinghu Road, Suite A-3, Bldg 21, Jiangsu Prov.,, Nantong, Jiangsu 226009
    Telephone
    Telephone
    +86-51385988868
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.novastlabs.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/novast-laboratories/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Novast’s Generics Drospirenone, Estradiol Receives Approval in Us
    Novast’s Generics Drospirenone, Estradiol Receives Approval in Us

    28 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218031

    FDA
    28 Oct 2025
    Share Share
    Novast’s Generics Conjugated Estrogens Receives Approval in US
    Novast’s Generics Conjugated Estrogens Receives Approval in US

    15 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214023

    FDA
    15 Oct 2025
    Share Share
    Novast’s Generics Diltiazem Hydrochloride Approved in US
    Novast’s Generics Diltiazem Hydrochloride Approved in US

    02 Jul 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218032

    FDA
    02 Jul 2025
    Share Share
    Novast’s Receives First Generic Approval for Mesna in US
    Novast’s Receives First Generic Approval for Mesna in US

    13 Jan 2025

    // FDA

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=218871

    FDA
    13 Jan 2025
    Share Share
    Novast labs`s Generics Cyclobenzaprine HCl Receives Approval in US
    Novast labs`s Generics Cyclobenzaprine HCl Receives Approval in US

    27 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214732

    FDA
    27 Aug 2024
    Share Share
    Novast`s Generics Mesalamine Receives Approval in US
    Novast`s Generics Mesalamine Receives Approval in US

    22 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218410

    FDA
    22 Aug 2024
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search